“Intravenous Immunoglobulin: A Potential Treatment for the Post-Acute Sequelae of SARS-Cov-2 Infection?”. 2022. Biomolecules and Biomedicine 22 (4): 660-64. https://doi.org/10.17305/bjbms.2021.6901.